Enteric Neuronal Regulation of Intestinal Inflammation

Trends in Neurosciences

Volumn 39, Issue 9, 2016, Pages 614-624

  Margolis, Kara Gross ^a   Gershon, Michael D ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

5 HT; enteric glia; enteric nervous system; inflammatory bowel disease; microbiome; neuroimmunity; serotonin

Indexed keywords

SEROTONIN;

ENTERITIS; GLIA CELL; HUMAN; IMMUNE SYSTEM; IMMUNITY; INTESTINE INNERVATION; MICROBIOME; NERVE CELL; NERVOUS SYSTEM; NEUROPROTECTION; PHYLOGENY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; ENTEROPATHY; IMMUNOMODULATION; INFLAMMATION; METABOLISM; MICROFLORA; PHYSIOLOGY;

ANIMALS; ENTERIC NERVOUS SYSTEM; HUMANS; INFLAMMATION; INTESTINAL DISEASES; MICROBIOTA; NEUROIMMUNOMODULATION; SEROTONIN;

EID: 84979633558     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2016.06.007     Document Type: Review

References (116)

1. 1 Ananthakrishnan, A.N., Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12 (2015), 205–217.
2. 2 Goyal, M.S., et al. Feeding the brain and nurturing the mind: linking nutrition and the gut microbiota to brain development. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 14105–14112.
3. 3 Sanchez de Medina, F., et al. Intestinal inflammation and mucosal barrier function. Inflamm. Bowel Dis. 20 (2014), 2394–2404.
4. 4 Furness, J.B., The enteric nervous system: normal functions and enteric neuropathies. Neurogastroenterol. Motil. 20:Suppl. 1 (2008), 32–38.
5. 5 Mayer, E.A., et al. Gut microbes and the brain: paradigm shift in neuroscience. J. Neurosci. 34 (2014), 15490–15496.
6. 6 Sampson, T.R., Mazmanian, S.K., Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17 (2015), 565–576.
7. 7 Forsythe, P., et al. Vagal pathways for microbiome–brain–gut axis communication. Adv. Exp. Med. Biol. 817 (2014), 115–133.
8. 8 Clark, K.B., et al. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat. Neurosci. 2 (1999), 94–98.
9. 9 Rush, A.J., et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol. Psychiatry 47 (2000), 276–286.
10. 10 Margolis, K.G., et al. Enteric neuronal density contributes to the severity of intestinal inflammation. Gastroenterology 141 (2011), 588–598.
11. 11 Costes, L.M., et al. Neural networks in intestinal immunoregulation. Organogenesis 9 (2013), 216–223.
12. 12 Steinhoff, M.S., et al. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol. Rev. 94 (2014), 265–301.
13. 13 Ottaviani, E., et al. Common evolutionary origin of the immune and neuroendocrine systems: from morphological and functional evidence to in silico approaches. Trends Immunol. 28 (2007), 497–502.
14. 14 Hartenstein, V., The neuroendocrine system of invertebrates: a developmental and evolutionary perspective. J. Endocrinol. 190 (2006), 555–570.
15. 15 Funayama, N., The stem cell system in demosponges: suggested involvement of two types of cells: archeocytes (active stem cells) and choanocytes (food-entrapping flagellated cells). Dev. Genes Evol. 223 (2013), 23–38.
16. 16 Kedees, M.H., et al. Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor. Peptides 48 (2013), 36–44.
17. 17 Mukherjee, S., Hooper, L.V., Antimicrobial defense of the intestine. Immunity 42 (2015), 28–39.
18. 18 Margolis, K.G., Gershon, M.D., Neuropeptides and inflammatory bowel disease. Curr. Opin. Gastroenterol. 25 (2009), 503–511.
19. 19 Buhner, S., Schemann, M., Mast cell–nerve axis with a focus on the human gut. Biochim. Biophys. Acta 1822 (2012), 85–92.
20. 20 Verheijden, S., et al. Neuron-macrophage crosstalk in the intestine: a ‘microglia’ perspective. Front. Cell. Neurosci., 9, 2015, 403.
21. 21 Cailotto, C., et al. Neuro-anatomical evidence indicating indirect modulation of macrophages by vagal efferents in the intestine but not in the spleen. PLoS ONE, 9, 2014, e87785.
22. 22 Muller, P.A., et al. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell 158 (2014), 300–313.
23. 23 Gabanyi, I., et al. Neuro-immune interactions drive tissue programming in intestinal macrophages. Cell 164 (2016), 378–391.
24. 24 Mawe, G.M., Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon. J. Clin. Invest. 125 (2015), 949–955.
25. 25 Neunlist, M., et al. Enteric glial cells: recent developments and future directions. Gastroenterology 147 (2014), 1230–1237.
26. 26 Sharkey, K.A., Emerging roles for enteric glia in gastrointestinal disorders. J. Clin. Invest. 125 (2015), 918–925.
27. 27 Brown, I.A., et al. Enteric glia mediate neuron death in colitis through purinergic pathways that require connexin-43 and nitric oxide. Cell. Mol. Gastroenterol. Hepatol. 2 (2016), 77–91.
28. 28 Gulbransen, B.D., et al. Activation of neuronal P2X7 receptor–pannexin-1 mediates death of enteric neurons during colitis. Nat. Med. 18 (2012), 600–604.
29. 29 Bush, T.G., et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93 (1998), 189–201.
30. 30 Kempermann, G., et al. Neurogenesis in the adult hippocampus. Cold Spring Harb. Perspect. Biol., 7, 2015, a018812.
31. 31 Gershon, M.D., Behind an enteric neuron there may lie a glial cell. J. Clin. Invest. 121 (2011), 3386–3389.
32. 32 Rao, M., et al. Enteric glia express proteolipid protein 1 and are a transcriptionally unique population of glia in the mammalian nervous system. Glia 63 (2015), 2040–2057.
33. 33 Boesmans, W., et al. Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system. Glia 63 (2015), 229–241.
34. 34 Gulbransen, B.D., Sharkey, K.A., Novel functional roles for enteric glia in the gastrointestinal tract. Nat. Rev. Gastroenterol. Hepatol. 9 (2012), 625–632.
35. 35 Nasser, Y., et al. Role of enteric glia in intestinal physiology: effects of the gliotoxin fluorocitrate on motor and secretory function. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006), G912–G927.
36. 36 Rao, M., Defining the role of glia in the enteric nervous system. J. Pediatr. Gastroenterol. Nutr., 61, 2015 Published online October 9, 2015. http://www.naspghan.org/files/Concurrent2_NeuroMotility_Rao_AM.pdf.
37. 37 Laranjeira, C., et al. Glial cells in the mouse enteric nervous system can undergo neurogenesis in response to injury. J. Clin. invest. 121 (2011), 3412–3424.
38. 38 Kabouridis, P.S., et al. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron 85 (2015), 289–295.
39. 39 Bernardini, N., et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J. Cell. Mol. Med. 16 (2012), 318–327.
40. 40 Furness, J.B., et al. Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog. Neurobiol. 72 (2004), 143–164.
41. 41 Linden, D.R., et al. Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon. J. Physiol. 547 (2003), 589–601.
42. 42 Krauter, E.M., et al. Synaptic plasticity in myenteric neurons of the guinea-pig distal colon: presynaptic mechanisms of inflammation-induced synaptic facilitation. J. Physiol. 581 (2007), 787–800.
43. 43 Lomax, A.E., et al. Synaptic facilitation and enhanced neuronal excitability in the submucosal plexus during experimental colitis in guinea-pig. J. Physiol. 564 (2005), 863–875.
44. 44 Roberts, J.A., et al. The roles of purinergic signaling during gastrointestinal inflammation. Curr. Opin. Pharmacol. 12 (2012), 659–666.
45. 45 Strong, D.S., et al. Purinergic neuromuscular transmission is selectively attenuated in ulcerated regions of inflamed guinea pig distal colon. J. Physiol. 588 (2010), 847–859.
46. 46 Roberts, J.A., et al. Oxidative stress disrupts purinergic neuromuscular transmission in the inflamed colon. J. Physiol. 591 (2013), 3725–3737.
47. 47 Linden, D.R., et al. Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon. Neurogastroenterol. Motil. 17 (2005), 751–760.
48. 48 Belkind-Gerson, J., et al. Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism. Inflamm. Bowel Dis. 21 (2015), 870–878.
49. 49 Hons, I.M., et al. Alterations to enteric neural signaling underlie secretory abnormalities of the ileum in experimental colitis in the guinea pig. Am. J. Physiol. Gastrointest. Liver Physiol. 296 (2009), G717–G726.
50. 50 Barada, K., et al. Electrocautery-induced localized colonic injury elicits increased levels of pro-inflammatory cytokines in small bowel and decreases jejunal alanine absorption. Cytokine 71 (2015), 109–118.
51. 51 Linden, D.R., Enhanced excitability of guinea pig ileum myenteric AH neurons during and following recovery from chemical colitis. Neurosci. Lett. 545 (2013), 91–95.
52. 52 Cocciolillo, S., Collins, S.M., The long-term functional consequences of acute infectious diarrhea. Curr. Opin. Gastroenterol. 32 (2016), 1–6.
53. 53 Spiller, R., Garsed, K., Postinfectious irritable bowel syndrome. Gastroenterology 136 (2009), 1979–1988.
54. 54 Goodrich, J.T., et al. Phylogeny of enteric serotonergic neurons. J. Comp. Neurol. 190 (1980), 15–28.
55. 55 Trandaburu, T., Trandaburu, I., Serotonin (5-hydroxytryptamine, 5-HT) immunoreactive endocrine and neural elements in the chromaffin enteropancreatic system of amphibians and reptiles. Acta Histochem. 109 (2007), 237–247.
56. 56 Grosell, M., et al. Fish Physiology: The Multifunctional Gut of Fish. 2010, Elsevier Science.
57. 57 Anderson, C., Campbell, G., Immunohistochemical study of 5-HT-containing neurons in the teleost intestine: relationship to the presence of enterochromaffin cells. Cell Tissue Res. 254 (1988), 553–559.
58. 58 Ahlman, H., Nilsson, The gut as the largest endocrine organ in the body. Ann. Oncol. 12:Suppl. 2 (2001), S63–S68.
59. 59 Latorre, R., et al. Enteroendocrine cells: a review of their role in brain-gut communication. Neurogastroenterol. Motil. 28 (2016), 620–630.
60. 60 Walther, D.J., et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299, 2003, 76.
61. 61 Li, Z., et al. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J. Neurosci. 31 (2011), 8998–9009.
62. 62 Cote, F., et al. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 13525–13530.
63. 63 Margolis, K.G., et al. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut 63 (2014), 928–937.
64. 3 receptors are membrane ion channels. Nature 339 (1989), 706–709.
65. 65 Stasi, C., et al. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech. Coloproctol. 18 (2014), 613–621.
66. 1A receptors in the nervous systems of the bowel and pancreas. J. Comp. Neurol. 364 (1996), 439–455.
67. 67 Glatzle, J., et al. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 123 (2002), 217–226.
68. 68 Liu, M., et al. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005), G1148–G1163.
69. 69 Poole, D.P., et al. Identification of neurons that express 5-hydroxytryptamine4 receptors in intestine. Cell Tissue Res. 325 (2006), 413–422.
70. 70 Tonini, M., et al. 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 129 (2005), 1557–1566.
71. 71 Yaakob, N.S., et al. Distribution of 5-HT3, 5-HT4, and 5-HT7 receptors along the human colon. J. Neurogastroenterol. Motil. 21 (2015), 361–369.
72. 72 Shajib, M.S., Khan, W.I., The role of serotonin and its receptors in activation of immune responses and inflammation. Acta physiologica. 213 (2015), 561–574.
73. 73 Blakely, R.D., et al. Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 196 (1994), 263–281.
74. 74 Margolis, K.G., et al. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J. Clin. Invest. 126 (2016), 2221–2235.
75. 75 Gershon, M.D., Review article: serotonin receptors and transporters–roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 20:Suppl. 7 (2004), 3–14.
76. 76 Beikmann, B.S., et al. Serotonin uptake is largely mediated by platelets versus lymphocytes in peripheral blood cells. ACS chem. Neurosci. 4 (2013), 161–170.
77. 77 Lesurtel, M., et al. Platelet-derived serotonin mediates liver regeneration. Science 312 (2006), 104–107.
78. 78 Kode, A., et al. Lrp5 regulation of bone mass and serotonin synthesis in the gut. Nat. Med. 20 (2014), 1228–1229.
79. 79 Weihe, E., et al. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5 (1994), 149–164.
80. 80 Gershon, M.D., Ross, L.L., Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor. J. Physiol. 186 (1966), 451–476.
81. 81 Gershon, M.D., et al. Type-specific localization of monoamine oxidase in the enteric nervous system: relatonship to 5-hydroxytryptamine, neuropeptides, and sympathetic nerves. J. Comp. Neurol. 301 (1990), 191–213.
82. 82 Baganz, N.L., Blakely, R.D., A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem. Neurosci. 4 (2013), 48–63.
83. 83 Manning, B.M., et al. Single-cell analysis of mast cell degranulation induced by airway smooth muscle-secreted chemokines. Biochim. Biophys. Acta 1850 (2015), 1862–1868.
84. 84 Arreola, R., et al. Immunomodulatory effects mediated by serotonin. J. Immunol. Res., 2015, 2015, 354957.
85. + antigen-specific clone or by specific monoclonal IgE antibody. Skin Pharmacol. 4:Suppl 1 (1991), 25–42.
86. 86 Askenase, P.W., et al. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 152 (1980), 1358–1374.
87. 87 Gershon, R.K., et al. Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions. J. Exp. Med. 142 (1975), 732–747.
88. 88 Thoa, N.B., et al. The accumulation of carbon 14-serotonin in the guinea-pig vas deferens. J. Pharmacol. Exp. Ther. 169 (1969), 68–73.
89. 89 Saito, A., Lee, T.J., Serotonin as an alternative transmitter in sympathetic nerves of large cerebral arteries of the rabbit. Circ. Res. 60 (1987), 220–228.
90. 90 Bischoff, S.C., et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 296 (2009), G685–G695.
91. 91 Ghia, J.E., et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 137 (2009), 1649–1660.
92. 92 Li, N., et al. Serotonin activates dendritic cell function in the context of gut inflammation. Am. J. Pathol. 178 (2011), 662–671.
93. 93 Kim, J.J., et al. Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation. J. Immunol. 190 (2013), 4795–4804.
94. 94 Guseva, D., et al. Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract. Inflamm. Bowel Dis. 20 (2014), 1516–1529.
95. 95 Idzko, M., et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J. Immunol. 172 (2004), 6011–6019.
96. 96 Linden, D.R., et al. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003), G207–G216.
97. 97 Linden, D.R., et al. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol. Motil. 17 (2005), 565–574.
98. 98 Spiller, R.C., et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47 (2000), 804–811.
99. 99 O'Hara, J.R., et al. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004), G998–G1007.
100. 100 Wang, Y., et al. Correlation between serum serotonin and endoscopy inflammation scores in patients with ileal pouches. J. Crohns Colitis 7 (2013), e133–e142.
101. 101 Coates, M.D., et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and IBS. Gastroentrology 126 (2004), 1657–1664.
102. 102 Sikander, A., et al. Association of serotonin transporter promoter polymorphism (5-HTTLPR) with microscopic colitis and ulcerative colitis. Dig. Dis. Sci. 60 (2015), 887–894.
103. 103 Chin, A., et al. The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 302 (2012), G397–G405.
104. 104 Kidd, M., et al. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol. Motil. 21 (2009), 439–450.
105. 105 Liu, M.T., et al. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J. Neurosci. 29 (2009), 9683–9699.
106. 106 Bianco, F., et al. Prucalopride exerts neuroprotection in human enteric neurons. Am. J. Physiol. Gastrointest. Liver Physiol. 310 (2016), G768–G775.
107. 107 Gershon, M.D., 5-HT4-mediated neuroprotection: a new therapeutic modality on the way?. Am. J. Physiol. Gastrointest. Liver Physiol. 310 (2016), G766–G767.
108. 108 Goto, K., et al. Activation of 5-HT4 receptors facilitates neurogenesis from transplanted neural stem cells in the anastomotic ileum. J. physiol. Sci. 66 (2016), 67–76.
109. 109 Gershon, M.D., Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans. Am. Clin. Climato. Assoc. 123 (2012), 268–280.
110. 110 Manuc, T.E., et al. Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets. Clin. Exp. Gastroenterol. 9 (2016), 59–70.
111. 111 Bassotti, G., et al. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. Int. J. Colorectal Dis. 19 (2004), 493–497.
112. 112 Rao, S.S., et al. Studies on the mechanism of bowel disturbance in ulcerative colitis. Gastroenterology 93 (1987), 934–940.
113. 113 Linden, D.R., et al. Cyclooxygenase-2 contributes to dysmotility and enhanced excitability of myenteric AH neurones in the inflamed guinea pig distal colon. J. Physiol. 557 (2004), 191–205.
114. 114 Hornby, P.J., Drug discovery approaches to irritable bowel syndrome. Expert Opin. Drug Discov. 10 (2015), 809–824.
115. 115 McElhanon, B.O., et al. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics 133 (2014), 872–883.
116. 116 Veenstra-VanderWeele, J., et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 5469–5474.